SUSPECTED OFF LABEL USE

This adverse event was reported 4522 times

These drugs are most commonly taken by patients reporting SUSPECTED OFF LABEL USE:

# Drug Count
0 RITUXIMAB 633
1 METHYLPREDNISOLONE 473
2 ACETAMINOPHEN 444
3 PREDNISONE 424
4 PAIN RELIEVER 386
5 ACETAMINOPHEN 500MG 385
6 ACETAMINOPHEN TABLET EXTENDED RELEASE 385
7 METHOTREXATE SODIUM 382
8 INFLIXIMAB 312
9 INFLIXIMAB-DYYB 311
See all common drugs associated with SUSPECTED OFF LABEL USE

SUSPECTED OFF LABEL USE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 USTEKINUMAB-STBA 45 0.1213
1 INFLIXIMAB-DYYB 311 0.0902
2 BEVACIZUMAB-ADCD 7 0.0345
3 MARSTACIMAB-HNCQ 3 0.0291
4 CARBOPROST TROMETHAMINE 15 0.0204
5 ELRANATAMAB-BCMM 23 0.0199
6 ASIAN GINSENG 6 0.0142
7 SPARSENTAN 95 0.0140
8 TRICLOSAN 7 0.0121
9 NAXITAMAB 3 0.0120
See all drugs enriched for association with SUSPECTED OFF LABEL USE